digital currency is the most popular application of, Featured

Musk praised Tesla China. According to the data, Tesla sold 21,900 vehicles in China last week (12.2-12.8), which was the second best week of Tesla in 2024 so far. The excellent sales performance in China market was highly recognized by Tesla CEO Musk, who praised "the excellent work of Tesla China" online on social media.Celeste's new patent can be used for early warning of safe driving according to sitting posture. Tianyuecha's intellectual property information shows that recently, the patent of "vehicle driving early warning method, device, electronic equipment and storage medium" applied by Celeste Automobile Co., Ltd. was announced. The method includes: collecting the sitting image of the vehicle driver, identifying the key points in the sitting image, using waist key points and shoulder key points to determine the current sitting centroid, comparing the current sitting centroid with the initial sitting centroid, generating a centroid deviation result, detecting whether the vehicle driver's sitting posture is abnormal according to the centroid deviation result, and giving an early warning prompt to the vehicle driver in response to determining that the vehicle driver's sitting posture is abnormal. According to the invention, the key points of the driver's waist and shoulders are intelligently detected through the sitting posture image to obtain the position of the triangle centroid of the driver's shoulder and waist, and the sitting posture is judged by adopting the sitting posture centroid, so that whether the driver's sitting posture is abnormal can be quickly and accurately recognized, the accuracy of judging the driving sitting posture is improved, the driving warning is automatically performed, and the effectiveness of safe driving of vehicles is ensured.Market news: Japan is considering levying a 4% corporate tax surcharge for national defense expenditure.

Sinotrans has set up a new company, including land international cargo transportation agency business. The enterprise search APP shows that recently, Sinotrans Logistics (Alashankou) Co., Ltd. was established with Chen Xin as its legal representative and registered capital of 10 million yuan. Its business scope includes: domestic container cargo transportation agency; International freight forwarder; Land international freight forwarding agent; Import and export agents, etc. Enterprise survey shows that the company is indirectly wholly-owned by Sinotrans.The semiconductor concept oscillated higher and Broadcom integrated daily limit, and the semiconductor concept oscillated higher and Broadcom integrated daily limit. Hengxuan Technology, Purran, Shanghai Beiling, Tailingwei and Dongxin shares rose more than 5%.Hong kong stocks minimally invasive robots rose more than 13%. The company completed the placement of a total of 34.7 million shares, and the net proceeds from the placement were about HK$ 266 million.

In 2024, the rating of brokerage investment banking business is nearing the end, and the results of 96 brokers will be released. The reporter was informed that the quality evaluation of brokerage investment banking business in 2024 is nearing the end, and the evaluation scores of investment banking business quality of 96 participating brokers in 2024 have been distributed to companies. After the brokers confirm, the association will start the formal scoring work. In September this year, the China Securities Association launched the quality evaluation of brokerage investment banking business in 2024, and initially determined the participating brokerage and investment banking projects. According to the preliminary statistics, about 68 brokers are expected to get extra points for supporting high-level science and technology in investment banking. (Cailian)Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.